Apr 16 |
Cullinan Shifts Focus From Oncology To Autoimmune Disorders, Raises $280M Via Equity
|
Apr 16 |
UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday
|
Apr 16 |
Cullinan Therapeutics expands into autoimmune diseases
|
Apr 16 |
Cullinan Therapeutics gets $280M via oversubscribed private placement
|
Apr 16 |
Cullinan Therapeutics Announces Strategic Expansion into Autoimmune Diseases
|
Apr 16 |
Cullinan Therapeutics Announces Oversubscribed $280 million Private Placement
|
Apr 16 |
Cullinan changes name, pivots to autoimmune disease
|
Mar 16 |
Cullinan Oncology Inc (CGEM) Reports Fourth Quarter and Full Year 2023 Financial Results
|
Mar 15 |
Here's Why We're Not Too Worried About Cullinan Oncology's (NASDAQ:CGEM) Cash Burn Situation
|
Mar 14 |
Cullinan Oncology GAAP EPS of -$0.54
|